AR048864A1 - Tabletas dispersables que comprenden un derivado de acido benzoico - Google Patents

Tabletas dispersables que comprenden un derivado de acido benzoico

Info

Publication number
AR048864A1
AR048864A1 ARP050101362A ARP050101362A AR048864A1 AR 048864 A1 AR048864 A1 AR 048864A1 AR P050101362 A ARP050101362 A AR P050101362A AR P050101362 A ARP050101362 A AR P050101362A AR 048864 A1 AR048864 A1 AR 048864A1
Authority
AR
Argentina
Prior art keywords
benzoic acid
acid derivative
available tablets
tablets
available
Prior art date
Application number
ARP050101362A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR048864A1 publication Critical patent/AR048864A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tabletas dispersables que comprenden como ingrediente activo, ácido 4-[3,5-bis(2-hidroxifenil)-[1,2,4]triazol-1-il]benzoico, o una sal farmacéuticamente aceptable del mismo, en una cantidad de 5 a 40% en peso, basado en el peso total de la tableta. Procedimiento.
ARP050101362A 2004-04-08 2005-04-06 Tabletas dispersables que comprenden un derivado de acido benzoico AR048864A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408078.4A GB0408078D0 (en) 2004-04-08 2004-04-08 Organic compounds

Publications (1)

Publication Number Publication Date
AR048864A1 true AR048864A1 (es) 2006-06-07

Family

ID=32320645

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101362A AR048864A1 (es) 2004-04-08 2005-04-06 Tabletas dispersables que comprenden un derivado de acido benzoico

Country Status (14)

Country Link
US (1) US20080312302A1 (es)
EP (1) EP1734924A1 (es)
JP (1) JP2007532509A (es)
CN (1) CN1997348A (es)
AR (1) AR048864A1 (es)
AU (2) AU2005230402A1 (es)
BR (1) BRPI0509645A (es)
CA (1) CA2559739A1 (es)
GB (1) GB0408078D0 (es)
PA (1) PA8629501A1 (es)
PE (1) PE20060717A1 (es)
RU (1) RU2396954C2 (es)
TW (1) TW200603841A (es)
WO (1) WO2005097062A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1945272B1 (en) 2005-11-01 2013-09-11 Novartis AG Method of scintigraphy
US20090317489A1 (en) 2006-05-09 2009-12-24 Hanspeter Nick Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof
WO2008005624A2 (en) * 2006-05-23 2008-01-10 Novartis Ag Method of treatment of hereditary hemochromatosis
JP2010511012A (ja) 2006-11-29 2010-04-08 ノバルティス アーゲー デフェラシロックス（ｉｃｌ６７０ａ）の多形形態
JPWO2010032489A1 (ja) 2008-09-22 2012-02-09 国立大学法人旭川医科大学 鉄キレート剤及びその製造方法、並びに鉄イオンの定量・捕捉方法
ES2543427T3 (es) * 2010-07-08 2015-08-19 Ratiopharm Gmbh Forma farmacéutica oral de deferasirox
PE20170468A1 (es) 2010-10-01 2017-04-26 Cipla Ltd Composicion farmaceutica que comprende deferasirox
EP2664333B1 (en) 2011-01-14 2016-10-12 Disease Adsorption System Technologies Co., Ltd. Polymeric iron chelating agent
AU2013343250A1 (en) 2012-11-12 2015-04-09 Cipla Limited Fixed dose pharmaceutical composition comprising deferasirox and deferipone
NZ711179A (en) * 2013-03-08 2018-07-27 Novartis Ag Oral formulations of deferasirox
AU2014264421A1 (en) 2013-05-10 2015-12-03 Cipla Limited Low dose pharmaceutical composition
TR201909052T4 (tr) 2014-05-20 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasiroks içeren suda dağılabilen tablet formülasyonu.
EP2987482A1 (en) 2014-08-22 2016-02-24 Santa Farma Ilaç Sanayi A.S. Soluble and dispersible pharamaceutical deferasirox formulation
WO2016167729A1 (en) 2015-04-16 2016-10-20 Öğün Yusuf Toktamiş Dispersible tablets comprising deferasirox
WO2018007956A1 (en) * 2016-07-05 2018-01-11 Jubilant Generics Limited Immediate release pharmaceutical composition of iron chelating agents
EP3518904A1 (en) 2016-09-30 2019-08-07 Synthon B.V. Pharmaceutical composition comprising deferasirox
CZ2017255A3 (cs) 2017-05-04 2018-11-14 Zentiva, K.S. Filmem potažené tablety Deferasiroxu
WO2018208242A1 (en) 2017-05-10 2018-11-15 İlko Ilaç Sanayi Ve Ticaret Anonim Şirketi Formulation of deferasirox tablet for oral suspension composition with better processability
EP3675832A1 (en) 2017-09-01 2020-07-08 Jordan Sweden Medical and Sterilization Company Fast self dispersible dosage forms of deferasirox
TR201722910A2 (tr) 2017-12-29 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Deferasi̇roks i̇çeren suda dağilabi̇len tablet formülasyonlari

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
DE4412117A1 (de) * 1994-04-08 1995-10-12 Fette Wilhelm Gmbh Verfahren und Vorrichtung zum Aufbringen von pulverförmigem Schmier- oder Trennmittel auf die Preßwerkzeuge in Tablettiermaschinen
TW533205B (en) * 1996-06-25 2003-05-21 Novartis Ag Substituted 3,5-diphenyl-l,2,4-triazoles and their pharmaceutical composition
AU741992B2 (en) * 1998-03-06 2001-12-13 Adare Pharmaceuticals S.R.L. Fast disintegrating tablets
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
EP1281264B1 (en) * 2000-05-08 2012-12-12 Broadcom Corporation System and method for supporting multiple voice channels
US20040122106A1 (en) * 2001-03-06 2004-06-24 Motohiro Ohta Tablets quickly disintegrating in oral cavity
GB0223978D0 (en) * 2002-10-15 2002-11-20 Novartis Ag Organic compound

Also Published As

Publication number Publication date
BRPI0509645A (pt) 2007-09-18
RU2006139000A (ru) 2008-05-20
CA2559739A1 (en) 2005-10-20
WO2005097062A1 (en) 2005-10-20
AU2009201696A1 (en) 2009-05-21
PA8629501A1 (es) 2005-11-25
TW200603841A (en) 2006-02-01
US20080312302A1 (en) 2008-12-18
PE20060717A1 (es) 2006-08-02
CN1997348A (zh) 2007-07-11
RU2396954C2 (ru) 2010-08-20
JP2007532509A (ja) 2007-11-15
EP1734924A1 (en) 2006-12-27
GB0408078D0 (en) 2004-05-12
AU2005230402A1 (en) 2005-10-20

Similar Documents

Publication Publication Date Title
AR048864A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
PA8586501A1 (es) Tabletas dispersables que comprenden un derivado de acido benzoico
AR039335A1 (es) Tableta de carga de droga alta
ECSP066807A (es) Formulaciones galénicas de compuestos orgánicos
ECSP088379A (es) Tabletas dispersables que comprenden deferasirox
EA201070588A1 (ru) Производные 1,2,3-триазола для применения в качестве ингибиторов стеароил-соа десатуразы
BR112013032122A2 (pt) liberação modificada de 4-metil-3-[[4-(3-piridinil)-2-pirimidinil]amino]-n-[5-(4-metil-1h-imidazol-1-il)-3-(trifluorometil)fenil] benzamida solubilizada usando ácidos orgânicos
NO20062004L (no) Forlenget frigjoring farmasoytiske blandinger omfattene aplindor og derivater derav
UY32816A (es) Formulación farmacéutica a base de 1-[2-(2,1,3-benzotiadiazol-5-ilamino)-6(2,6-diclorofenil)-pirido[2,3-d] pirimidin-7-il]-3-tert-butil-uréa
HK1147202A1 (en) Orally disintegrated dosage form
UA109421C2 (uk) Фармацевтична композиція, яка містить ліганди сигма-рецептора
ECSP12011699A (es) Tableta
TN2010000120A1 (en) Galenical formulations of organic compounds
PE20070012A1 (es) Formulaciones farmaceuticas de liberacion inmediata y con una carga de droga elevada de (4-clorofenil)[4-(4-piridilmetil) ftalazin-1-ilo] micronizado, y sus sales
WO2008065144A3 (en) Galenic formulations of organic compounds
TW200607498A (en) Agents for prevention or treatment of diseases associated with endothelial hyperproliferation
CR7539A (es) Tableta con alto contenido de farmacos
ECSP045380A (es) Tableta con alta carga de fármaco
AR057264A1 (es) Composicion farmaceutica
TH103172A (th) ยาผสมตามสูตรมาตรฐานของสารประกอบอินทรีย์
TH79600A (th) รูปแบบยาของแข็งที่ให้ทางปากที่มีขนาดของเอสตราไดออลต่ำ

Legal Events

Date Code Title Description
FB Suspension of granting procedure